{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:43:29Z","timestamp":1792424609047,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.brainres.2012.02.042","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T13:20:53Z","timestamp":1330089653000},"page":"148-156","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Motor function and dopamine release measurements in transgenic Huntington's disease model rats"],"prefix":"10.1016","volume":"1450","author":[{"given":"Andrea N.","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Lauderdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von H\u00f6rsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2012.02.042_bb0010","series-title":"Huntington's Disease","author":"Bates","year":"2002"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2012.02.042_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2004.01.021","article-title":"Early exploratory behavior abnormalities in R6\/1 Huntington's disease transgenic mice","volume":"1005","author":"Bolivar","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2012.02.042_bb0025","unstructured":"Brooks, S.P., Janghra, N., Workman, V.L., Bayram-Weston, Z., Jones, L., Dunnett, S.B., in press. Longitudinal analysis of the behavioural phenotype in R6\/1 (C57BL\/6J) Huntington's disease transgenic mice. Brain Res. Bull."},{"issue":"61","key":"10.1016\/j.brainres.2012.02.042_bb0030","first-page":"1","article-title":"In vivo dopamine efflux is decreased in striatum of both fragment (R6\/2) and full-length (YAC128) transgenic mouse models of Huntington's disease","volume":"5","author":"Callahan","year":"2011","journal-title":"Front Syst Neurosci."},{"issue":"8","key":"10.1016\/j.brainres.2012.02.042_bb0035","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2012.02.042_bb0040","series-title":"The Biochemical Basis of Neuropharmacology","author":"Cooper","year":"2003"},{"key":"10.1016\/j.brainres.2012.02.042_bb0045","doi-asserted-by":"crossref","unstructured":"Creese, I., Iversen, S.D., 1975. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res. 83, 419\u2013436.","DOI":"10.1016\/0006-8993(75)90834-3"},{"key":"10.1016\/j.brainres.2012.02.042_bb0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2012.02.042_bb0055","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0448","article-title":"From neuronal inclusions to neurodegeneration: neuropathological investigation of a transgenic mouse model of Huntington's disease","volume":"354","author":"Davies","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.brainres.2012.02.042_bb0060","first-page":"1","article-title":"Synaptic vesicle pools: an update","volume":"2","author":"Denker","year":"2010","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.brainres.2012.02.042_bb0240","first-page":"203","article-title":"Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model","volume":"208","author":"Fischer","year":"1979","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2012.02.042_bb0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-0270(01)00359-4","article-title":"A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor","volume":"107","author":"Fowler","year":"2001","journal-title":"J. Neurosci. Methods"},{"issue":"2","key":"10.1016\/j.brainres.2012.02.042_bb0245","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00213-003-1528-5","article-title":"Behavioral sensitization to amphetamine in rats: changes in the rhythm of head movements during focused stereotypies","volume":"170","author":"Fowler","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.brainres.2012.02.042_bb0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00213-007-0705-3","article-title":"Clozapine and prazosin slow the rhythm of head movements during focused stereotypy induced by d-amphetamine in rats","volume":"192","author":"Fowler","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.brainres.2012.02.042_bb0250","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbr.2009.03.022","article-title":"Force-plate quantification of progressive behavioral deficits in the R6\/2 mouse model of Huntington's disease","volume":"202","author":"Fowler","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"5985","key":"10.1016\/j.brainres.2012.02.042_bb0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/311461a0","article-title":"The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems","volume":"311","author":"Gerfen","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2012.02.042_bb0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-4159.2002.00804.x","article-title":"The role of DA in motor symptoms in the R6\/2 transgenic mouse model of Huntington's disease","volume":"81","author":"Hickey","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2012.02.042_bb0125","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","article-title":"DA release is severely compromised in the R6\/2 mouse model of Huntington's disease","volume":"97","author":"Johnson","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2012.02.042_bb0130","doi-asserted-by":"crossref","unstructured":"Kelly, P.H., Seviour, P.W., Iversen, S.D., 1975. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94, 507\u2013522.","DOI":"10.1016\/0006-8993(75)90233-4"},{"key":"10.1016\/j.brainres.2012.02.042_bb0135","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1097\/00001756-199912160-00031","article-title":"Intranuclear inclusions in subtypes of striatal neurons in Huntington's disease transgenic mice","volume":"10","author":"Kosinski","year":"1999","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.brainres.2012.02.042_bb0140","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.neuroscience.2009.03.083","article-title":"In vivo DA release and uptake impairments in rats treated with 3-nitropropionic acid","volume":"161","author":"Kraft","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2012.02.042_bb0145","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/0006-2952(82)90057-0","article-title":"Evidence for carrier-mediated efflux of dopamine from corpus striatum","volume":"31","author":"Liang","year":"1982","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.brainres.2012.02.042_bb0260","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","article-title":"Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect","volume":"27","author":"Levine","year":"2004","journal-title":"Trends Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2012.02.042_bb0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(01)00261-3","article-title":"Evaluation of R6\/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus","volume":"126","author":"L\u00fcesse","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2012.02.042_bb0290","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2012.02.042_bb0160","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0306-4522(00)00391-2","article-title":"Amyloid-like inclusions in Huntington's disease","volume":"100","author":"McGowan","year":"2000","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.brainres.2012.02.042_bb0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","article-title":"Mouse models of Huntington's disease","volume":"23","author":"Menalled","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.brainres.2012.02.042_bb0270","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1602\/neurorx.2.3.465","article-title":"Knock-in mouse models of Huntington's disease","volume":"2","author":"Menalled","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.brainres.2012.02.042_bb0295","first-page":"451","article-title":"The actions of amphetamine on neurotransmitters: a brief review","volume":"12","author":"Moore","year":"1977","journal-title":"Biol. Psychiatry"},{"issue":"21","key":"10.1016\/j.brainres.2012.02.042_bb0175","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1093\/hmg\/ddl394","article-title":"Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease","volume":"15","author":"Nguyen","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.brainres.2012.02.042_bb0180","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.neuroscience.2003.08.053","article-title":"Molecular and behavioral analysis of the R6\/1 Huntington's disease transgenic mouse","volume":"122","author":"Naver","year":"2003","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.brainres.2012.02.042_bb0185","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1471-4159.2009.06501.x","article-title":"Dysregulation of intracellular DA stores revealed in the R6\/2 mouse striatum","volume":"112","author":"Ortiz","year":"2010","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.brainres.2012.02.042_bb0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2011.01.036","article-title":"Impaired DA release and uptake in R6\/1 Huntington's disease model mice","volume":"492","author":"Ortiz","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.brainres.2012.02.042_bb0195","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/nbdi.2002.0534","article-title":"Evidence for dysfunction of the nigrostriatal pathway in the R6\/1 line of transgenic Huntington's disease mice","volume":"11","author":"Peters\u00e9n","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2012.02.042_bb0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn1583","article-title":"Synaptic vesicle pools","volume":"6","author":"Rizzoli","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2012.02.042_bb0205","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","article-title":"Huntingtin-ended polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo","volume":"90","author":"Scherzinger","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2012.02.042_bb0210","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.brainres.2012.02.042_bb0275","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1745-7254.2006.00410.x","article-title":"Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies","volume":"27","author":"Wang","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.brainres.2012.02.042_bb0230","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddg075","article-title":"Transgenic rat model of Huntington's disease","volume":"12","author":"von H\u00f6rsten","year":"2003","journal-title":"Hum. Mol. Genet."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899312003484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899312003484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T03:51:36Z","timestamp":1561348296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899312003484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":39,"alternative-id":["S0006899312003484"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2012.02.042","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}